Measurement of short-term, intermediate, and long-term outcomes of treating hypertension

Cardiology Clinics

Volumn 14, Issue 1, 1996, Pages 131-142

  Weber, M A ^a   Radensky, P ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

COST BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY MONITORING; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LIFESTYLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 0030038434     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70266-6     Document Type: Article

References (20)

1. J.R. Caldwell S. Cobb M.D. Dowling The dropout problem in antihypertensive treatment J Chron Dis 22 1970 579 592
2. S.H. Croog S. Levine M.A. Testa The effects of antihypertensive therapy on the quality of life N Engl J Med 314 1986 1657 1664
3. B. Dahlof L. Lundholm L. Hansson Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet 338 1991 1281 1285
4. K.C. Farmer E.W. Jacobs C.R. Phillips Long-term patient compliance with prescribed regimens of calcium channel blockers Clin Therap 16 1994 316 326
5. Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure The Fifth Report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNC V) Arch Intern Med 153 1993 154 183
6. Medical Research Council Working Party MRC trial of treatment in mild hypertension: Principal results BMJ 291 1985 97 104
7. A.J. Naftilan R. Williams D. Burt A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension Hypertension 14 1989 614 618
8. National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension Arch Intern Med 153 1993 186
9. J.M. Neutel D.H.G. Smith W.F. Graettinger Heredity and hypertension: Impact on metabolic characteristics Am Heart J 124 1992 435 440
10. L.M. Prisant M. Weir V. Papademetriou Low dose drug combination therapy: An alternative first line approach to hypertension treatment Am Heart J 130 1995 359 362
11. Report by the Management Committee: The Australian Therapeutic Trial in Mild Hypertension Lancet 1 1980 1261 1267
12. D.D. Savage J.M. Drayer W.L. Henry Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects Circulation 59 1979 623 632
13. D.A. Sclar T.L. Skaer A. Chin Utility of a transdermal delivery system for antihypertensive therapy: Part 1 Am J Med 91 suppl 1991 50S 56S
14. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
15. L. Tobian Editorials on government guidelines Am J Hypertens 7 1994 857 858
16. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mmHg JAMA 202 1967 1028 1034
17. M.A. Weber Coronary heart disease and hypertension Am J Hypertens 7 suppl 1993 146S 153S
18. M.A. Weber The changing focus of hypertension Curr Opin Neph Hypertens 4 1995 218 222
19. M.A. Weber J.H. Laragh Hypertension: Steps forward and steps backward Arch Intern Med 153 1993 149 152
20. M.A. Weber D.H.G. Smith J.M. Neutel Cardiovascular and metabolic characteristics of hypertension Am J Med 91 suppl 1 1991 1A 4S